Quidel Posts 21 Percent Revenue Growth for Q4 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market Wednesday that its fourth-quarter revenues increased 21 percent year over year driven by its infectious disease and women's health products.

The San Diego-based diagnostics firm generated total revenues of $38.4 million for the three-month period ended Dec. 31, 2011, compared to $31.7 million for Q4 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

A survey of Cincinnati schoolchildren finds teenagers want to know their genetic predisposition to disease, LiveScience reports.

More and more universities are helping their researchers patent their inventions, the Los Angeles Times reports.

Cancer Research UK unveils seven 'grand challenges' that it will fund researchers to tackle.